ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO2300

Provider Practice Evaluation Survey: Assessment of Primary Care Provider Perspectives on Care Delivery for CKD Patients in Alberta

Session Information

Category: CKD (Non-Dialysis)

  • 2101 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention


  • Bello, Aminu K., University of Alberta, Edmonton, Alberta, Canada
  • Zaidi, Deenaz, University of Alberta, Edmonton, Alberta, Canada
  • Ye, Feng, University of Alberta, Edmonton, Alberta, Canada
  • Okpechi, Ikechi G., University of Alberta, Edmonton, Alberta, Canada

Chronic kidney disease (CKD) is highly prevalent in the adult population of Canada, with a steady rise in end-stage renal disease. The objective of this study was to assess current modes of practice regarding CKD patients, and assess barrier and facilitators in primary care for managing and referring CKD patients using electronic consultation (eReferral).


The Provider Practice Evaluation Survey was launched for primary care providers [PCPs (family physicians or general practitioners)] licensed to practice in Alberta. Associations between barriers and facilitators to electronic consultations and clinic practice parameters; and associations between screening for CKD in patients and clinic practice parameters were analyzed. Modified Poisson regression with robust error variance was used to estimate the relative risk (RR) and 95% confidence interval.


A total of 48 PCPs responded to the survey. Awareness about the availability of the eReferral tool was more likely to be a barrier to use eReferral for PCPs of South Zone as compared to PCPs from Edmonton (RR: 2.00, 95% CI: 1.07-3.74). Compared to PCPs with >5% CKD patients in their clinical practice, PCPs with 16% to 26% CKD patients were more likely to perceive barriers to use eReferral; including the ease of use for the eReferral tool (RR: 1.62, 95% CI: 1.05-2.51), and limited staff and technical support as a barrier for eReferral (RR: 2.00, 95%CI: 1.18-3.40). There was a negative association between PCPs aged between 40 and 60 years and time constraints as a barrier compared with those younger than 40 years (RR: 0.66, 95% CI: 0.46-0.95). Regarding screening tools (criteria) to diagnose CKD, PCPs who had not used the eReferral tools were less likely to use hypertension (RR: 0.86, 95% CI: 0.75-0.98), diabetes (RR: 0.89, 95% CI: 0.79-0.999), and cardiovascular disease (RR: 0.72, 95% CI: 0.59-0.89) as CKD diagnostic tools compared to those using eReferral nephrology advice request tool.


The results will help implement innovative steps to rectify barriers to adoption of the eReferral system and standardized CKD diagnostic guidelines to improve patient care in Canada.